More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies

OBJECTIVE: To define the clinical phenotype of dermatomyositis (DM) with anti-Mi2 autoantibodies. METHODS: In this longitudinal cohort study, the prevalence and severity of clinical features at disease onset and during follow-up in patients with anti-Mi2–positive DM were compared to patients with an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurology
Autors principals: Pinal-Fernandez, Iago, Mecoli, Christopher A., Casal-Dominguez, Maria, Pak, Katherine, Hosono, Yuji, Huapaya, Julio, Huang, Wilson, Albayda, Jemima, Tiniakou, Eleni, Paik, Julie J., Johnson, Cheilonda, Danoff, Sonye K., Corse, Andrea M., Christopher-Stine, Lisa, Mammen, Andrew L.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946486/
https://ncbi.nlm.nih.gov/pubmed/31594859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008443
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars